Bioliberty Ltd raised $335,906 (Edinburgh, X0)

LIVE PUBLIC DATA Source: SEC EDGAR Form D filings (U.S. Securities and Exchange Commission) · Last refreshed: Wed, 04 Nov 2026 15:17:01 GMT

Bioliberty Ltd plus every comparable record, with all columns and source links, as one CSV.

Not investment advice and not an offer or solicitation to buy or sell any security.

56 / 100 vendor spend propensity

Estimated post-raise budget for CPA / Tax / Audit services: $6,718 (heuristic)

  • Operating company: new capital typically funds hiring, facilities and vendors.
  • Raised $335,906 so far: a smaller raise.
  • Technology & SaaS companies are a strong fit for CPA / Tax / Audit services.
  • New filing (not an amendment): the raise is fresh.
FieldValue
IndustryOther Technology (Technology & SaaS)
Operating companyYes
Exemption506(b)
Amount sold$335,906
Total offering$660,905
Investors so far2
First sale2026-10-16
Filed2026-10-26
EntityOther

Executives and related persons (from the filing)

  • Barry Hextall: Executive Officer
  • Rowan Armstrong: Director
  • Conan Bradley: Director
  • Shea Quinn: Director
  • Ross O'Hanlon: Director
  • Ramy El-Madany: Director
  • David O'Reilly: Director
  • Russell Bailey: Director
  • Dana Strauss: Director
  • Albert Nicholl: Director

View the filing on SEC EDGAR

Markdown version

Bioliberty Ltd vs. top 3 peers

OrganizationLocationCapital raisedRecord date
Bioliberty LtdEdinburgh$335,9062026-10-26
Caplens CorpLondon$235,0002026-10-23
RESOLV TECHNOLOGY, INC.Manchester$7,171,9852026-10-30
Step Into AI Inc.Chicago$8,165,9982026-11-03

Related records

Newly funded Technology & SaaS companies (SEC Form D)

Get new raises like this every morning

FormDPulse emails you newly funded companies that match your ideal customer profile.

See plans

Often used together

Or get the Advisor Prospecting Bundle for $14.99 one-time: Full CSV unlock of newly funded companies plus a grant readiness pack.